Most men prescribed a PDE5 inhibitor receive a conventional tablet to swallow with water. The orally disintegrating formulation of vardenafil takes a different approach. It dissolves on the tongue within seconds, needs no liquid, and was developed for men who want discretion or who struggle with swallowing tablets. It is a distinct product rather than a cosmetic reformulation, and the difference carries clinical consequences.
What the ODT Formulation Actually Is
Vardenafil is a phosphodiesterase type 5 inhibitor licensed for erectile dysfunction. It blocks the enzyme that breaks down cyclic GMP in the corpus cavernosum, allowing the vasodilation triggered by sexual arousal to be sustained. Without arousal there is no nitric oxide release and the drug does nothing, which is worth stating plainly given the persistent misconception that these medicines create desire.
The orodispersible version has been marketed under brand names including Staxyn and Levitra Orodispersible, with generic equivalents available in several markets. It is peppermint flavoured and comes in one strength only: 10 mg. That single strength is the source of most of the prescribing nuance discussed below.
The Critical Point: ODT and Film Coated Tablets Are Not Interchangeable
This is the detail most often missed at the counter. A 10 mg orodispersible tablet does not deliver the same systemic exposure as a 10 mg film coated tablet. Pharmacokinetic studies show the ODT produces a higher area under the curve, meaning greater total drug exposure. The two presentations are therefore not bioequivalent and cannot be substituted for one another on a milligram for milligram basis.
A man stabilised on 20 mg of the swallowed tablet should not assume two 10 mg orodispersible tablets are equivalent, and a man who tolerated 10 mg of the film coated version may notice more pronounced effects from the orodispersible form. Any switch between presentations is a new prescribing decision.
How to Take It Correctly
Handling matters more here than with a standard tablet, and poor technique is a common reason for a disappointing first experience.
- Take the tablet with dry hands. Moisture begins the disintegration process immediately.
- Peel back the foil on the blister rather than pushing the tablet through it. The tablet is fragile and will crumble under pressure.
- Place it on the tongue and allow it to dissolve. Do not chew, crush, or split it.
- Take it without water. Washing it down with liquid defeats the purpose of the formulation and may alter absorption.
- Use it approximately 60 minutes before anticipated sexual activity, and no more than once in any 24 hour period.
Keep the tablets in their original blister packs up to the point of consumption because the drug form is hygroscopic and will be degraded once it is exposed to moisture. The drug should be stored in an environment where the temperature is less than 30°C and not in bathrooms because moisture is expected there.
Availability of the orodispersible form differs between locations. Some forms of the drug have been removed from commercial markets even though the molecular form is still approved.
Who Is a Good Candidate
The formulation suits men who find swallowing tablets difficult, whether because of dysphagia after stroke, oesophageal disease, or simple aversion, and those who value discretion. Registration trials showed improvements in International Index of Erectile Function scores and in successful penetration and completion rates comparable to the conventional presentation, including in men with diabetes.
Who Should Avoid It
Because 10 mg is the only available strength, the orodispersible tablet cannot be dose reduced. Any patient who would ordinarily require a lower starting dose is therefore better served by the film coated tablet, which is available at 2.5 mg and 5 mg. That includes:
- Men aged 65 and over, who show meaningfully higher plasma concentrations.
- Those with moderate hepatic impairment, classified as Child Pugh class B.
- Men taking alpha blockers such as tamsulosin or doxazosin for prostate symptoms, where cautious titration is required to avoid symptomatic hypotension and falls.
- Anyone taking a moderate or potent CYP3A4 inhibitor, including ketoconazole, itraconazole, clarithromycin, ritonavir, or indinavir, all of which substantially raise vardenafil levels.
Severe hepatic impairment and end stage renal disease requiring dialysis have not been adequately studied and are generally avoided. One further point specific to this formulation: it contains aspartame and therefore phenylalanine, which is relevant for anyone with phenylketonuria.
Contraindications and Interactions
Nitrates in any form, including nitroglycerin, isosorbide mononitrate or dinitrate, and recreational nitrite inhalants, are an absolute contraindication. The combination can precipitate a catastrophic fall in blood pressure. The same applies to riociguat, a soluble guanylate cyclase stimulator used in pulmonary hypertension.
Vardenafil carries a modest QT prolonging effect, so it should not be combined with class IA antiarrhythmics such as quinidine or procainamide, or class III agents such as amiodarone or sotalol. It is also avoided in congenital long QT syndrome.
Men with unstable angina, uncontrolled arrhythmia, uncontrolled hypertension or significant hypotension, or a myocardial infarction or stroke within the preceding six months should defer treatment pending cardiology review. Previous non arteritic anterior ischaemic optic neuropathy is a reason to avoid the whole drug class.
Side Effects Worth Knowing
The adverse effect profile of men's health PDE5 inhibitor therapy mirrors that of other PDE5 inhibitors and primarily reflects vasodilation. Headache is the most frequent adverse effect, followed by facial flushing, nasal congestion, dyspepsia, and dizziness. These effects are usually mild and often diminish with repeated use.
Rare but urgent problems warrant immediate medical attention: an erection lasting beyond four hours, sudden loss or reduction of vision in one or both eyes, sudden hearing loss or tinnitus, and chest pain during sexual activity.
Storage and Practical Counselling
Keep the tablets in their original blister packs up to the point of consumption because the drug form is hygroscopic and will be degraded once it is exposed to moisture. The drug should be stored in an environment where the temperature is less than 30°C and not in bathrooms because moisture is expected there.
Availability of the orodispersible form differs between locations. Some forms of the drug have been removed from commercial markets even though the molecular form is still approved.
Vardenafil is a prescription only medicine requiring assessment of cardiovascular fitness and a full medication review before it is started. Erectile dysfunction is also frequently the first visible sign of vascular disease or undiagnosed diabetes, reason enough for the underlying cause to be investigated rather than simply managed with a tablet.
